uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
15.35
-0.74 (-4.63%)
Mar 23, 2026, 12:34 PM EDT - Market open
uniQure Market Cap
uniQure has a market cap or net worth of $959.51 million as of March 23, 2026. Its market cap has increased by 41.83% in one year.
Market Cap
959.51M
Enterprise Value
903.27M
1-Year Change
41.83%
Ranking
Category
Stock Price
$15.35
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $959.51M, an increase of 495.60%. That is a compound annual growth rate of 21.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.01B | -32.50% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tevogen Bio Holdings | 1.06B |
| AbCellera Biologics | 1.05B |
| Bicara Therapeutics | 1.02B |
| Savara | 1.02B |
| ArriVent BioPharma | 980.83M |
| Geron | 973.63M |
| Xeris Biopharma Holdings | 957.86M |
| Aktis Oncology | 956.43M |